Summary
We report a hemophilia B kindred in which the proband has a complete deletion of the factor IX gene extending a minimum of 80 kilobase pairs (kb) 3′ of the gene. This individual has severe factor IX deficiency with no detectable circulating factor IX protein. In common with one previous report, despite a total deletion of the factor IX gene, this patient has not developed antibodies to factor IX. The mother of the proband was found to have a new TaqI variant of the factor IX gene on the nondeletion-bearing X chromosome. The location of the altered TaqI site was found to be 5′ of exon IV between residues 9731-9734 and does not affect the function of the factor IX protein. The familial natures of both the variant allele and the deletion were established. In addition a study of this kindred at the DXS99 locus demonstrated the first reported recombination event between this site and the factor IX gene.
Similar content being viewed by others
References
Anson DS, Choo KH, Rees DJG, Giannelli G, Gould K, Huddleston JA, Brownlee GG (1984) Gene structure of human anti-haemophilic factor IX. EMBO J 3:1053–1064
Antonarakis SE (1988) The molecular genetics of hemophilia A and B in man (factor VIII: C and factor IX deficiency) Adv Hum Genet (in press)
Antonarakis SE, Waber PG, Kittur SD, Patel AS, Kazazian HH Jr, Mellis MA, Counts RB, Stamatoyannopoulos G, Bowie EJW, Fass DN, Pittman DD, Wozney JM, Toole JJ (1985) Hemophilia A: molecular defects and carrier detection by DNA analysis. N Engl J Med 313:842–848
Bernardi F, DelSenno L, Barbieri R, Buzzoni D, Gambari R, Marchetti G, Conconi F, Panicucci F, Positano M, Pitrazello S (1985) Gene deletion in an Italian hemophilia B subject. J Med Genet 22:305–307
Briet E, Reisner HM, Roberts HR (1984) Inhibitors in Christmas disease. In: Hoyer LW (ed) Factor VIII inhibitors. Liss, New York pp 123–129
Chen SH, Yoshitake S, Chance PF, Bray GL, Thompson AR, Scott CR, Kurachi K (1985) An intragenic deletion of the factor IX gene in a family with hemophilia B. J Clin Invest 76:2161–2164
Fulcher CA, Graaf Mahoney S de, Roberts JR, Kasper CK, Zimmerman TS (1985) Localization of human factor VIII inhibitor epitopes to two polypeptide fragments. Proc Natl Acad Sci USA 82:7728–7732
Giannelli F, Choo KH, Rees DJG, Boyd Y, Rizza CR, Brownlee GG (1983) Gene deletion in patients with hemophilia B and antifactor IX antibodies. Nature 303:181–182
Giannelli F, Choo KH, Winship PR, Rizza CR, Anson DS, Rees DJG, Ferrari N, Brownlee GG (1984) Characterization and use of an intragenic polymorphic marker for detection of carriers of hemophilia B (factor IX deficiency). Lancet I:239–241
Gitschier J, Wood WI, Tuddenham EGD, Shuman MA, Goralka TM, Chen EY, Lawn RM (1985) Detection and sequence of mutations in the factor VIII gene of hemophiliacs. Nature 315:427–430
Hassan HJ, Leonardi A, Guerriero R, Chelucci C, Cianetti L, Ciavarella N, Ranieri P, Pilolli D, Peschle C (1985) Hemophilia B with inhibitor molecular analysis of the subtotal deletion of the factor IX gene. Blood 66:728–730
Jackson CM, Nemerson Y (1980) Blood coagulation. Annu Rev Biochem 49:765–811
Kasper CK, Aledort LM, Aronson D, Count RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, Van Eyes J (1975) A more uniform measurement of factor VIII inhibitor. Thromb Diath Haemorrh 34:869–872
Matthews RJ, Anson DS, Peake IR, Bloom AL (1987) Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. J Clin Invest 79:746–753
McKee PA (1983) Haemostasis and disorders of blood coagulation. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1531–1560
Mulligan LM, Phillips MA, Forster-Gibson CJ, Beckett J, Partington MW, Simpson NE, Holden JJA, White BN (1985) Genetic mapping of DNA segments relative to the locus for the fragile-X syndrome at Xq27.3. Am J Hum Genet 37:463–472
Mulligan L, Holden JJA, White BN (1987) A DNA marker closely linked to the factor IX (haemophilia B) gene. Hum Genet 75: 381–383
Peake IR, Furlong BL, Bloom AL (1984) Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency) Lancet I:242–243
Poon MC, Chui DHK, Patterson M, Starozik DM, Dimnik LS, Hoar DI (1987) Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. J Clin Invest 79:1204–1209
Rizza CR, Spooner RJD (1983) Treatment of heamophilia and related disorders in Britain and Northern Ireland during 1976–80: report on behalf of the directors of haemophilia centres in the United Kingdom. Br Med J 286:929–933
Tanimoto K, Kojima T, Takamatsu J, Kamiya T, Ogata K, Inagaki M, Iizuka A, Nagao T, Kurachi K, Saito H (1986) Gene analysis of hemophilia B in Japan. Blood 68:348a (abstr)
Vidaud M, Chabret C, Gazengel C, Grunebaum L, Cazenave JP, Goossens M (1986) A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. Blood 68:961–963
Wadelius C, Goonewardena P, Blomback M, Johnson H, Anvret M, Lindstedt M, Gustavson KH, Lindsten J, Petterson U (1986) Gross deletion of F9 gene, causing severe hemophilia B. RFLP analysis of hemophilia A and B. 7th International Congress of Human Genetics, Berlin, 1986, p 654
Willard HF, Skolnick MH, Pearson PL, Mandel J-L (1985) Report of the committee on human gene mapping by recombinant DNA techniques. Cytogenet Cell Genet 40:360–489
Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K (1985) Nucleotide sequence of the gene for human factor IX. Biochemistry 24:3736–3750
Youssouffian H, Kazazian HH Jr, Phillips DG, Aronis S, Tsiftis G, Brown VA, Antonarakis SE (1986) Recurrent mutations in hemophilia give evidence for CpG mutation hotspots. Nature 324:380–382
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, S.A.M., Lillicrap, D.P., Blanchette, V. et al. A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred. Hum Genet 79, 273–276 (1988). https://doi.org/10.1007/BF00366250
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00366250